BioDelivery Sciences International Director Unloads $37,875 in Stock (BDSI)
BioDelivery Sciences International (NASDAQ:BDSI) Director Samuel Sears, Jr. sold 7,500 shares of BioDelivery Sciences International stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $5.05, for a total transaction of $37,875.00. Following the completion of the sale, the director now directly owns 25,853 shares in the company. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
BDSI has been the subject of a number of recent research reports. Analysts at Roth Capital raised their price target on shares of BioDelivery Sciences International (NASDAQ:BDSI) from $7.00 to $8.50 in a research note to investors on Monday, August 12th. Analysts at Ladenburg Thalmann raised their price target on shares of BioDelivery Sciences International (NASDAQ:BDSI) from $7.25 to $9.00 in a research note to investors on Friday, August 2nd. They now have a “buy” rating on the stock.
BioDelivery Sciences International (NASDAQ:BDSI) traded up 0.76% during mid-day trading on Tuesday, hitting $5.27. The stock had a trading volume of 324,712 shares. BioDelivery Sciences International has a 52-week low of $3.52 and a 52-week high of $6.89. The stock has a 50-day moving average of $4.65 and a 200-day moving average of $4.. The company’s market cap is $200.4 million.
BioDelivery Sciences International, Inc (NASDAQ:BDSI) is a specialty pharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.